Trial record 1 of 1 for:    ct011 hcv
Previous Study | Return to List | Next Study

Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00962936
Recruitment Status : Terminated
First Posted : August 20, 2009
Last Update Posted : August 29, 2014
Teva Pharmaceutical Industries
Information provided by (Responsible Party):
CureTech Ltd

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2011
  Actual Study Completion Date : January 2013